Lutz Jermutus

6.2k citations

84 papers · 4.5k indexed · 3 hit papers · h-index 36

Impact in

Radiology, Nuclear Medicine and Imaging top 0.5%
- Monoclonal and Polyclonal Antibodies Research
Endocrinology, Diabetes and Metabolism top 1%
- Diabetes Treatment and Management

Papers in

Radiology, Nuclear Medicine and Imaging 40
- Monoclonal and Polyclonal Antibodies Research 40
Endocrinology, Diabetes and Metabolism 23
- Diabetes Treatment and Management 21

Co-authors: Andreas Plückthun Jozef Hanes Daniel Christ Phil Ambery David C. Lowe Annemarie Honegger Christiane Schaffitzel Ralph Minter
Journals: Proceedings of the National Academy of Sciences (6 papers)Diabetes (5 papers)Protein Engineering Design and Selection (4 papers)Scientific Reports (3 papers)mAbs (3 papers)
Partner nations: United Kingdom Sweden United States

In The Last Decade

Lutz Jermutus

81 papers receiving 4.3k citations

Hit Papers

align trajectories log scale

Advances in antibody-based therapy in oncology 2023 · 117 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 Nature Cancer
2021 Diabetes Care
2020 Nature Metabolism

Peers

Countries citing papers authored by Lutz Jermutus

Since Specialization

Citations

This map shows the geographic impact of Lutz Jermutus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lutz Jermutus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lutz Jermutus more than expected).

Fields of papers citing papers by Lutz Jermutus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lutz Jermutus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lutz Jermutus. The network helps show where Lutz Jermutus may publish in the future.

Co-authors

The 25 scholars most cited alongside Lutz Jermutus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lutz Jermutus Line = papers co-authored together Lutz Jermutus links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Exenatide and glucagon co-infusion increases myocardial glucose uptake and improves markers of diastolic dysfunction in adults with type 2 diabetes Scientific Reports ·James Goodman, Martin Schain, Giovanni Di Stefano, Victoria Lupson, T. Horn, Marion E. Hill, Roido Manavaki, Timothy D. Fryer, Elaine Bumanlag-Amis, Navazh Jalaludeen, Lutz Jermutus, Edvin Johansson, Kerstin Heurling, Henrik Haraldsson, Mark L. Evans, Joseph Cheriyan, L. E. B. Johansson, Phil Ambery, Ian B. Wilkinson	2025	0
2	Cotadutide promotes glycogenolysis in people with overweight or obesity diagnosed with type 2 diabetes Nature Metabolism ·Victoria Parker, Darren Robertson, Edmundo Erazo‐Tapia, Bas Havekes, Esther Phielix, Marlies de Ligt, Kay H. M. Roumans, Julian Mevenkamp, Folke Sjöberg, Vera B. Schrauwen‐Hinderling, Edvin Johansson, Yi‐Ting Chang, Russell Esterline, Kenneth Smith, Daniel J. Wilkinson, Lars Hansen, L. E. B. Johansson, Phil Ambery, Lutz Jermutus, Patrick Schrauwen	2023	35
3	Glucagon and exenatide improve contractile recovery following ischaemia/reperfusion in the isolated perfused rat heart Physiological Reports ·Ross T. Lindsay, Phil Ambery, Lutz Jermutus, Andrew J. Murray	2023	6
4	Evolution of protease activation and specificity via alpha-2-macroglobulin-mediated covalent capture Nature Communications ·Philipp Knyphausen, Mariana Rangel Pereira, P. Brear, Marko Hyvönen, Lutz Jermutus, Florian Hollfelder	2023	8
5	The Common H202D Variant in GDF-15 Does Not Affect Its Bioactivity but Can Significantly Interfere with Measurement of Its Circulating Levels The Journal of Applied Laboratory Medicine ·Yanislava Karusheva, Matthew Ratcliff, Alexander Mörseburg, Peter Barker, Audrey Melvin, Naveed Sattar, Keith Burling, Anna Backmark, Robert Roth, Lutz Jermutus, Esther Guiu‐Jurado, Matthias Blüher, Paul Welsh, Marko Hyvönen, Stephen O’Rahilly	2022	19
6	Follicular helper T cell profiles predict response to costimulation blockade in type 1 diabetes Nature Immunology ·Natalie M. Edner, Frank Heuts, Niclas Thomas, Chun Jing Wang, Lina Petersone, Rupert Kenefeck, Alexandros Kogimtzis, Vitalijs Ovcinnikovs, Ellen M. Ross, Elisavet Ntavli, Yassin Elfaki, Martin Eichmann, Roman Baptista, Phil Ambery, Lutz Jermutus, Mark Peakman, Miranda Rosenthal, Lucy S. K. Walker	2020	66
7	Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status PLoS ONE ·Craig J. Currie, Ellen Berni, Thomas R. Berni, Sara Jenkins‐Jones, Marvin Sinsakul, Lutz Jermutus, Phil Ambery, Meena Jain	2019	29
8	Hospital admissions for severe infections in people with chronic kidney disease in relation to renal disease severity and diabetes status Endocrinology Diabetes & Metabolism ·Ellen Berni, Nicholas Pritchard, Sara Jenkins‐Jones, Phil Ambery, Meena Jain, Lutz Jermutus, Laura A. Scott, Craig J. Currie	2018	3
9	Combinatorial Screening Identifies Novel Promiscuous Matrix Metalloproteinase Activities that Lead to Inhibition of the Therapeutic Target IL-13 Chemistry & Biology ·Carole Urbach, Nathaniel C. Gordon, Ian Strickland, David Lowne, Cathy Joberty-Candotti, Richard May, Athula Herath, DirkJan Hijnen, Judith L. Thijs, Carla A.F.M. Bruijnzeel-Koomen, Ralph Minter, Florian Hollfelder, Lutz Jermutus	2015	12
10	Challenges and opportunities for non-antibody scaffold drugs Drug Discovery Today ·Rodrigo Vazquez-Lombardi, Tri Giang Phan, Carsten Zimmermann, David C. Lowe, Lutz Jermutus, Daniel Christ	2015	177
11	Identification of anti-tumour biologics using primary tumour models, 3-D phenotypic screening and image-based multi-parametric profiling Molecular Cancer ·Alan M. Sandercock, Steven Rust, Sandrine Guillard, Kris F. Sachsenmeier, Nick Holoweckyj, Carl Hay, Matt Flynn, Qihui Huang, Kuan Yan, Bram Herpers, Leo Price, Jo Soden, Jim Freeth, Lutz Jermutus, Robert E. Hollingsworth, Ralph Minter	2015	35
12	The effect of pH dependence of antibody-antigen interactions on subcellular trafficking dynamics mAbs ·Siva Charan Devanaboyina, Sandra Lynch, Raimund J. Ober, Sripad Ram, Dong Young Kim, Alberto Puig-Canto, Shannon Breen, Srinath Kasturirangan, Susan B. Fowler, Li Peng, Haihong Zhong, Lutz Jermutus, Herren Wu, Carl I. Webster, E. Sally Ward, Changshou Gao	2013	53
13	Structural and Pharmacological Characterization of Novel Potent and Selective Monoclonal Antibody Antagonists of Glucose-dependent Insulinotropic Polypeptide Receptor Journal of Biological Chemistry ·Peter Ravn, Chaithanya Madhurantakam, Susan Kunze, Evelyn Matthews, Claire Priest, Siobhan O’Brien, Andie Collinson, Monika Papworth, Maria Fritsch-Fredin, Lutz Jermutus, Lambertus Benthem, M.G. Gruetter, Ronald H. Jackson	2013	76
14	A series of Fas receptor agonist antibodies that demonstrate an inverse correlation between affinity and potency Cell Death and Differentiation ·Matthieu Chodorge, Sara Züger, Christian U. Stirnimann, Christophe Briand, Lutz Jermutus, Markus G. Grütter, Ralph Minter	2012	65
15	Expression of high-affinity human antibody fragments in bacteria Nature Protocols ·Romain Rouet, David C. Lowe, Kip Dudgeon, Brendan Roome, Peter R. Schofield, David B. Langley, John L. Andrews, Peter L Whitfeld, Lutz Jermutus, Daniel Christ	2012	58
16	Isolation of a Small‐Molecule Inhibitor of the Antiapoptotic Protein Bcl‐xL from a DNA‐Encoded Chemical Library ChemMedChem ·Samu Melkko, Luca Mannocci, Christoph E. Dumelin, Alessandra Villa, Roberto Sommavilla, Yixin Zhang, Markus G. Grütter, Nadine Keller, Lutz Jermutus, Ronald H. Jackson, Jörg Scheuermann, Dario Neri	2010	41
17	Current methods for the generation of human antibodies for the treatment of autoimmune diseases Drug Discovery Today ·Jane Osbourn, Lutz Jermutus, Alex Duncan	2003	33
18	In vitro selection and evolution of proteins Advances in protein chemistry ·Andreas Plückthun, Christiane Schaffitzel, Jozef Hanes, Lutz Jermutus	2001	42
19	Comparison ofEscherichia coliand rabbit reticulocyte ribosome display systems FEBS Letters ·Jozef Hanes, Lutz Jermutus, Christiane Schaffitzel, Andreas Plückthun	1999	49
20	Disordered C-terminal domain of tyrosyl-tRNA synthetase: Secondary structure prediction Biochimie ·Lutz Jermutus, Valérie Guez, Hugues Bedouelle	1999	1

About Lutz Jermutus

Lutz Jermutus is a scholar working on Radiology, Nuclear Medicine and Imaging, Endocrinology, Diabetes and Metabolism, Molecular Biology, Pharmacology and Immunology, having authored 84 papers that have together received 4.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (40 papers), Diabetes Treatment and Management (21 papers), Protein purification and stability (15 papers), RNA and protein synthesis mechanisms (15 papers), Glycosylation and Glycoproteins Research (10 papers), T-cell and B-cell Immunology (9 papers), Metabolism, Diabetes, and Cancer (7 papers) and Diet and metabolism studies (6 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.7k citations), Endocrinology, Diabetes and Metabolism (909 citations), Endocrine and Autonomic Systems (272 citations), Molecular Biology (2.6k citations) and Immunology (508 citations). Lutz Jermutus has collaborated with scholars based in United Kingdom, Sweden and United States. Frequent co-authors include Andreas Plückthun, Jozef Hanes, Daniel Christ, Phil Ambery, David C. Lowe, Annemarie Honegger, Christiane Schaffitzel, Ralph Minter, Cristina M. Rondinone and Boaz Hirshberg. Their work appears in journals such as Proceedings of the National Academy of Sciences, Diabetes, Protein Engineering Design and Selection, Scientific Reports and mAbs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact